-
Abreu CM, Veenhuis RT, Avalos CR, 2019: Myeloid and CD4 T cells comprise the latent reservoir in antiretroviral therapy-suppressed SIVmac251-infected Macaques[J]. MBio, 10, e01659-e1719. doi: 10.1128/mBio.01659-19
-
Al-Harthi L, Voris J, Patterson BK, 2004: Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients[J]. HIV Med, 5, 55-65. doi: 10.1111/j.1468-1293.2004.00186.x
-
Anzinger JJ, Butterfield TR, Angelovich TA, 2014: Monocytes as regulators of inflammation and HIV-related comorbidities during cART[J]. J Immunol Res, 2014, 569819-. doi: 10.1155/2014/569819
-
Auld E, Lin J, Chang E, 2016: HIV infection is associated with shortened Telomere length in Ugandans with Suspected Tuberculosis[J]. PLoS ONE, 11, e0163153-. doi: 10.1371/journal.pone.0163153
-
Ballegaard V, Brændstrup P, Pedersen KK, 2018: Cytomegalovirus-specific T-cells are associated with immune senescence, but not with systemic inflammation, in people living with HIV[J]. Sci Rep, 8, 3778-. doi: 10.1038/s41598-018-21347-4
-
Barsov EV, 2011: Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy[J]. Immunotherapy, 3, 407-421. doi: 10.2217/imt.10.107
-
Belge K-U, Dayyani F, Horelt A, 2002: The proinflammatory CD14 + CD16 + DR ++ monocytes are a major source of TNF[J]. J Immunol, 168, 3536-3542. doi: 10.4049/jimmunol.168.7.3536
-
Bertram KM, Botting RA, Baharlou H, 2019: Identification of HIV transmitting CD11c+ human epidermal dendritic cells[J]. Nat Commun, 10, 2759-. doi: 10.1038/s41467-019-10697-w
-
Blackburn SD, Wherry EJ, 2007: IL-10, T cell exhaustion and viral persistence[J]. Trends Microbiol, 15, 143-146. doi: 10.1016/j.tim.2007.02.006
-
Boasso A, Shearer GM, Chougnet C, 2009: Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?[J]. J Intern Med, 265, 78-96. doi: 10.1111/j.1365-2796.2008.02043.x
-
Borrow P, Bhardwaj N, 2008: Innate immune responses in primary HIV-1 infection[J]. Curr Opin HIV AIDS, 3, 36-44. doi: 10.1097/COH.0b013e3282f2bce7
-
Botting RA, Rana H, Bertram KM, 2017: Langerhans cells and sexual transmission of HIV and HSV[J]. Rev Med Virol, 27, e1923-. doi: 10.1002/rmv.1923
-
Boyette LB, Macedo C, Hadi K, 2017: Phenotype, function, and differentiation potential of human monocyte subsets[J]. PLoS ONE, , e0176460-. doi: 10.1371/journal.pone.0176460
-
Brenchley JM, 2013: Mucosal immunity in human and simian immunodeficiency lentivirus infections[J]. Mucosal Immunol, 6, 657-665. doi: 10.1038/mi.2013.15
-
Brenchley JM, Karandikar NJ, Betts MR, 2003: Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells[J]. Blood, 101, 2711-2720. doi: 10.1182/blood-2002-07-2103
-
Brenchley JM, Price DA, Schacker TW, 2006: Microbial translocation is a cause of systemic immune activation in chronic HIV infection[J]. Nat Med, 12, 1365-1371. doi: 10.1038/nm1511
-
Brenchley JM, Schacker TW, Ruff LE, 2004: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract[J]. J Exp Med, 200, 749-759. doi: 10.1084/jem.20040874
-
Brooks DG, Trifilo MJ, Edelmann KH, 2006: Interleukin-10 determines viral clearance or persistence in vivo[J]. Nat Med, 12, 1301-1309. doi: 10.1038/nm1492
-
Buscher K, Marcovecchio P, Hedrick CC, Ley K, 2017: Patrolling mechanics of non-classical monocytes in vascular inflammation[J]. Front Cardiovasc Med, 4, 80-. doi: 10.3389/fcvm.2017.00080
-
Carrington M, Alter G, 2012: Innate immune control of HIV[J]. Cold Spring Harb Perspect Med, 2, a007070-.
-
Cassol E, Malfeld S, Mahasha P, 2010: Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy[J]. J Infect Dis, 202, 723-733. doi: 10.1086/655229
-
Chang JJ, Altfeld M, 2010: Innate immune activation in primary HIV-1 infection[J]. J Infect Dis, 202, S297-S301. doi: 10.1086/655657
-
Chou JP, Effros RB, 2013: T cell replicative senescence in human aging[J]. Curr Pharm Des, 19, 1680-1698.
-
Christiaansen A, Varga SM, Spencer JV, 2015: Viral manipulation of the host immune response[J]. Curr Opin Immunol, 36, 54-60. doi: 10.1016/j.coi.2015.06.012
-
Clerici M, Shearer GM, 1993: A TH1->TH2 switch is a critical step in the etiology of HIV infection[J]. Immunol Today, 14, 107-111. doi: 10.1016/0167-5699(93)90208-3
-
Cohen MS, Shaw GM, McMichael AJ, Haynes BF, 2011: Acute HIV-1 infection[J]. N Engl J Med, 364, 1943-1954. doi: 10.1056/NEJMra1011874
-
Cormican S, Griffin MD, 2020: Human monocyte subset distinctions and function: insights from gene expression analysis[J]. Front Immunol, 11, 1070-. doi: 10.3389/fimmu.2020.01070
-
Creagh EM, O'Neill LAJ, 2006: TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity[J]. Trends Immunol, 27, 352-357. doi: 10.1016/j.it.2006.06.003
-
De Smedt T, Van Mechelen M, De Becker G, 1997: Effect of interleukin-10 on dendritic cell maturation and function[J]. Eur J Immunol, 27, 1229-1235. doi: 10.1002/eji.1830270526
-
Deeks SG, 2011: HIV infection, inflammation, immunosenescence, and aging[J]. Annu Rev Med, 62, 141-155. doi: 10.1146/annurev-med-042909-093756
-
Duncan CJA, Russell RA, Sattentau QJ, 2013: High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacy[J]. AIDS, 27, 2201-2206. doi: 10.1097/QAD.0b013e3283632ec4
-
Ellery PJ, Tippett E, Chiu Y-L, 2007: The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo[J]. J Immunol, 178, 6581-6589. doi: 10.4049/jimmunol.178.10.6581
-
Espíndola MS, Soares LS, Galvão-Lima LJ, 2018: Epigenetic alterations are associated with monocyte immune dysfunctions in HIV-1 infection[J]. Sci Rep, 8, 5505-. doi: 10.1038/s41598-018-23841-1
-
Février M, Dorgham K, Rebollo A, 2011: CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis[J]. Viruses, 3, 586-612. doi: 10.3390/v3050586
-
Funderburg NT, Lederman MM, 2014: Coagulation and morbidity in treated HIV infection[J]. Thromb Res, 133, S21-S24.
-
Funderburg NT, Mayne E, Sieg SF, 2010: Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation[J]. Blood, 115, 161-167. doi: 10.1182/blood-2009-03-210179
-
Funderburg NT, Zidar DA, Shive C, 2012: Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome[J]. Blood, 120, 4599-4608. doi: 10.1182/blood-2012-05-433946
-
Geissmann F, Jung S, Littman DR, 2003: Blood monocytes consist of two principal subsets with distinct migratory properties[J]. Immunity, 19, 71-82. doi: 10.1016/S1074-7613(03)00174-2
-
Ghattas A, Griffiths HR, Devitt A, 2013: Monocytes in coronary artery disease and atherosclerosis: where are we now?[J]. J Am Coll Cardiol, 62, 1541-1551. doi: 10.1016/j.jacc.2013.07.043
-
Giorgi JV, Liu Z, Hultin LE, 1993: Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up[J]. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr, 6, 904-912. doi: 10.1016/0928-8244(93)90068-F
-
Gren ST, Rasmussen TB, Janciauskiene S, 2015: A single-cell gene-expression profile reveals inter-cellular heterogeneity within human monocyte subsets[J]. PLoS ONE, 10, e0144351-. doi: 10.1371/journal.pone.0144351
-
Hamers AAJ, Dinh HQ, Thomas GD, 2019: Human monocyte heterogeneity as revealed by high-dimensional mass cytometry[J]. Arterioscler Thromb Vasc Biol, 39, 25-36. doi: 10.1161/ATVBAHA.118.311022
-
Hearps AC, Maisa A, Cheng W-J, 2012: HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy[J]. AIDS, 26, 843-853. doi: 10.1097/QAD.0b013e328351f756
-
Hilgendorf I, Swirski FK, 2012: Making a difference: monocyte heterogeneity in cardiovascular disease[J]. Curr Atheroscler Rep, 14, 450-459. doi: 10.1007/s11883-012-0274-8
-
Hunt PW, 2007: Role of immune activation in HIV pathogenesis[J]. Curr HIV/AIDS Rep, 4, 42-47. doi: 10.1007/s11904-007-0007-8
-
Jaroenpool J, Rogers KA, Pattanapanyasat K, 2007: Differences in the constitutive and SIV infection induced expression of Siglecs by hematopoietic cells from non-human primates[J]. Cell Immunol, 250, 91-104. doi: 10.1016/j.cellimm.2008.01.009
-
Kedzierska K, Crowe SM, 2001: Cytokines and HIV-1: interactions and clinical implications[J]. Antivir Chem Chemother, 12, 133-150. doi: 10.1177/095632020101200301
-
Kedzierska K, Crowe SM, Turville S, Cunningham AL, 2003: The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages[J]. Rev Med Virol, 13, 39-56. doi: 10.1002/rmv.369
-
Kestens L, Vanham G, Vereecken C, 1994: Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection[J]. Clin Exp Immunol, 95, 436-441. doi: 10.1111/j.1365-2249.1994.tb07015.x
-
Klatt NR, Silvestri G, Hirsch V, 2012: Nonpathogenic simian immunodeficiency virus infections[J]. Cold Spring Harb Perspect Med, 2, a007153-. doi: 10.1101/cshperspect.a007153
-
Klein SA, Dobmeyer JM, Dobmeyer TS, 1997: Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry[J]. AIDS, 11, 1111-1118. doi: 10.1097/00002030-199709000-00005
-
Kruize Z, Kootstra NA, 2019: The role of macrophages in HIV-1 persistence and pathogenesis[J]. Front Microbiol, 10, 2828-. doi: 10.3389/fmicb.2019.02828
-
Kuller LH, Tracy R, Belloso W, 2008: Inflammatory and coagulation biomarkers and mortality in patients with HIV infection[J]. PLoS Med, 5, e203-. doi: 10.1371/journal.pmed.0050203
-
Kumar A, Abbas W, Herbein G, 2013: TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?[J]. Mediators Inflamm, 2013, 484378-. doi: 10.1155/2013/484378
-
Kumar H, Kawai T, Akira S, 2009: Toll-like receptors and innate immunity[J]. Biochem Biophys Res Commun, 388, 621-625. doi: 10.1016/j.bbrc.2009.08.062
-
Land WG, 2015: The role of damage-associated molecular patterns in human diseases: Part Ⅰ - Promoting inflammation and immunity[J]. Sultan Qaboos Univ Med J, 15, e9-e21.
-
Lawn SD, Butera ST, Folks TM (2001) Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 14:753–777, table of contents.
-
Lee SA, Sinclair E, Jain V, 2014: Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection[J]. J Infect Dis, 210, 374-382. doi: 10.1093/infdis/jiu109
-
Levi M, Keller TT, van Gorp E, ten Cate H, 2003: Infection and inflammation and the coagulation system[J]. Cardiovasc Res, 60, 26-39. doi: 10.1016/S0008-6363(02)00857-X
-
Levy E, Xanthou G, Petrakou E, 2009: Distinct roles of TLR4 and CD14 in LPS-induced inflammatory responses of neonates[J]. Pediatr Res, 66, 179-184. doi: 10.1203/PDR.0b013e3181a9f41b
-
Lindmark E, Tenno T, Chen J, Siegbahn A, 1998: IL-10 inhibits LPS-induced human monocyte tissue factor expression in whole blood[J]. Br J Haematol, 102, 597-604. doi: 10.1046/j.1365-2141.1998.00808.x
-
Loo Y-M, Fornek J, Crochet N, 2008: Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity[J]. J Virol, 82, 335-345. doi: 10.1128/JVI.01080-07
-
Mascola JR, Haynes BF, 2013: HIV-1 neutralizing antibodies: understanding nature's pathways[J]. Immunol Rev, 254, 225-244. doi: 10.1111/imr.12075
-
Meier A, Alter G, Frahm N, 2007: MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands[J]. J Virol, 81, 8180-8191. doi: 10.1128/JVI.00421-07
-
Merino KM, Allers C, Didier ES, Kuroda MJ, 2017: Role of Monocyte/Macrophages during HIV/SIV Infection in Adult and Pediatric Acquired Immune Deficiency Syndrome[J]. Front Immunol, 8, 1693-. doi: 10.3389/fimmu.2017.01693
-
Miller MM, Petty CS, Tompkins MB, Fogle JE, 2014: CD4+CD25+ T regulatory cells activated during feline immunodeficiency virus infection convert T helper cells into functional suppressors through a membrane-bound TGFβ / GARP-mediated mechanism[J]. Virol J, 11, 7-. doi: 10.1186/1743-422X-11-7
-
Mogensen T, Melchjorsen J, Larsen C, Paludan S, 2010: Innate immune recognition and activation during HIV infection[J]. Retrovirology, 7, 54-. doi: 10.1186/1742-4690-7-54
-
Mukherjee R, Kanti Barman P, Kumar Thatoi P, 2015: Non-classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous[J]. Sci Rep, 5, 13886-. doi: 10.1038/srep13886
-
Nahrendorf M, Swirski FK, Aikawa E, 2007: The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions[J]. J Exp Med, 204, 3037-3047. doi: 10.1084/jem.20070885
-
Nakagawa F, May M, Phillips A, 2013: Life expectancy living with HIV[J]. Curr Opin Infect Dis, 26, 17-25. doi: 10.1097/QCO.0b013e32835ba6b1
-
Nazli A, Chan O, Dobson-Belaire WN, 2010: Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation[J]. PLoS Pathog, 6, e1000852-. doi: 10.1371/journal.ppat.1000852
-
Norris PJ, Pappalardo BL, Custer B, 2006: Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection[J]. AIDS Res Hum Retroviruses, 22, 757-762. doi: 10.1089/aid.2006.22.757
-
Nyamweya S, Hegedus A, Jaye A, 2013: Comparing HIV-1 and HIV-2 infection: lessons for viral immunopathogenesis[J]. Rev Med Virol, 23, 221-240. doi: 10.1002/rmv.1739
-
Ong S-M, Hadadi E, Dang T-M, 2018: The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence[J]. Cell Death Dis, 9, 266-. doi: 10.1038/s41419-018-0327-1
-
Ownby RL, Kumar AM, Benny Fernandez J, 2009: Tumor necrosis factor-alpha levels in HIV-1 seropositive injecting drug users[J]. J Neuroimmune Pharmacol, 4, 350-358. doi: 10.1007/s11481-009-9150-x
-
Paiardini M, Müller-Trutwin M, 2013: HIV-associated chronic immune activation[J]. Immunol Rev, 254, 78-101. doi: 10.1111/imr.12079
-
Palmer S, Wiegand AP, Maldarelli F, 2003: New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma[J]. J Clin Microbiol, 41, 4531-4536. doi: 10.1128/JCM.41.10.4531-4536.2003
-
Pandrea I, Sodora DL, Silvestri G, Apetrei C, 2008: Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts[J]. Trends Immunol, 29, 419-428. doi: 10.1016/j.it.2008.05.004
-
Pasquereau S, Kumar A, Herbein G, 2017: Targeting TNF and TNF receptor pathway in HIV-1 infection: from immune activation to viral reservoirs[J]. Viruses, 9, 64-. doi: 10.3390/v9040064
-
Patel AA, Zhang Y, Fullerton JN, 2017: The fate and lifespan of human monocyte subsets in steady state and systemic inflammation[J]. J Exp Med, 214, 1913-1923. doi: 10.1084/jem.20170355
-
Pena-Cruz V, Agosto LM, Akiyama H, 2018: HIV-1 replicates and persists in vaginal epithelial dendritic cells[J]. J Clin Invest, 128, 3439-3444. doi: 10.1172/JCI98943
-
Pinzone MR, Di Rosa M, Cacopardo B, Nunnari G, 2012: HIV RNA suppression and immune restoration: can we do better?[J]. Clin Dev Immunol, 2012, 1-12. doi: 10.1155/2012/515962
-
Prabhakar B, Banu A, Pavithra HB, 2011: Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy[J]. Indian J Sex Transm Dis AIDS, 32, 94-98. doi: 10.4103/0253-7184.85412
-
Prabhu VM, Singh AK, Padwal V, 2019: Monocyte based correlates of immune activation and Viremia in HIV-infected long-term non-progressors[J]. Front Immunol, 10, 2849-. doi: 10.3389/fimmu.2019.02849
-
Pulliam L, 2014: Cognitive consequences of a sustained monocyte type 1 IFN response in HIV-1 infection[J]. Curr HIV Res, 12, 77-84. doi: 10.2174/1570162X12666140526113544
-
Reuter MA, Pombo C, Betts MR, 2012: Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines[J]. Cytokine Growth Factor Rev, 23, 181-191. doi: 10.1016/j.cytogfr.2012.05.005
-
Roff SR, Noon-Song EN, Yamamoto JK, 2014: The significance of interferon-γ in HIV-1 pathogenesis, therapy, and prophylaxis[J]. Front Immunol, 4, 498-. doi: 10.3389/fimmu.2013.00498
-
Rogacev KS, Cremers B, Zawada AM, 2012: CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography[J]. J Am Coll Cardiol, 60, 1512-1520. doi: 10.1016/j.jacc.2012.07.019
-
Rogacev KS, Zawada AM, Emrich I, 2014: Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease[J]. Arterioscler Thromb Vasc Biol, 34, 2120-2127. doi: 10.1161/ATVBAHA.114.304172
-
Rossol M, Heine H, Meusch U, 2011: LPS-induced cytokine production in human monocytes and macrophages[J]. Crit Rev Immunol, 31, 379-446. doi: 10.1615/CritRevImmunol.v31.i5.20
-
Röszer T, 2018: Understanding the biology of self-renewing macrophages[J]. Cells, 7, 103-. doi: 10.3390/cells7080103
-
Sabbah A, Chang TH, Harnack R, 2009: Activation of innate immune antiviral responses by Nod2[J]. Nat Immunol, 10, 1073-1080. doi: 10.1038/ni.1782
-
Sabin CA, 2013: Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?[J]. BMC Med, 11, 251-. doi: 10.1186/1741-7015-11-251
-
Said EA, Dupuy FP, Trautmann L, 2010: Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection[J]. Nat Med, 16, 452-459. doi: 10.1038/nm.2106
-
Schutte RJ, Parisi-Amon A, Reichert WM, 2009: Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistries[J]. J Biomed Mater Res A, 88, 128-139. doi: 10.1002/jbm.a.31863
-
Semeraro F, Ammollo CT, Semeraro N, Colucci M, 2009: Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins[J]. Haematologica, 94, 819-826. doi: 10.3324/haematol.2008.000042
-
Si Y, Tsou C-L, Croft K, Charo IF, 2010: CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice[J]. J Clin Invest, 120, 1192-1203. doi: 10.1172/JCI40310
-
Sokol CL, Luster AD, 2015: The chemokine system in innate immunity[J]. Cold Spring Harb Perspect Biol, 7, a016303-. doi: 10.1101/cshperspect.a016303
-
Sonza S, Mutimer HP, Oelrichs R, 2001: Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy[J]. AIDS, 15, 17-22. doi: 10.1097/00002030-200101050-00005
-
Stansfield BK, Ingram DA, 2015: Clinical significance of monocyte heterogeneity[J]. Clin Transl Med, 4, 5-. doi: 10.1186/s40169-014-0040-3
-
Teer E, Joseph DE, Driescher N, 2019: HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations[J]. Am J Physiol Heart Circ Physiol, 316, H1146-H1157. doi: 10.1152/ajpheart.00797.2018
-
Wallet MA, Rodriguez CA, Yin L, 2010: Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy[J]. AIDS, 24, 1281-1290. doi: 10.1097/QAD.0b013e328339e228
-
Wilson EB, Brooks DG, 2011: The role of IL-10 in regulating immunity to persistent viral infections[J]. Curr Top Microbiol Immunol, 350, 39-65. doi: 10.1007/82_2010_96
-
Wilson EMP, Sereti I, 2013: Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs[J]. Immunol Rev, 254, 343-354. doi: 10.1111/imr.12064
-
Woollard KJ, Geissmann F, 2010: Monocytes in atherosclerosis: subsets and functions[J]. Nat Rev Cardiol, 7, 77-86. doi: 10.1038/nrcardio.2009.228
-
Wong KL, Tai JJ-Y, Wong W-C, 2011: Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets[J]. Blood, 118, e16-31. doi: 10.1182/blood-2010-12-326355
-
Wong ME, Jaworowski A, Hearps AC, 2019: The HIV reservoir in monocytes and macrophages[J]. Front Immunol, 10, 1435-. doi: 10.3389/fimmu.2019.01435
-
World Health Organization (WHO) (2020) WHO | Data and statistics. In: WHO HIV/AIDS Data Stat. https://www.who.int/hiv/data/en/. Accessed 7 Jul 2020
-
Yang J, Zhang L, Yu C, 2014: Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases[J]. Biomark Res, 2, 1-. doi: 10.1186/2050-7771-2-1
-
Zawada AM, Rogacev KS, Schirmer SH, 2012: Monocyte heterogeneity in human cardiovascular disease[J]. Immunobiology, 217, 1273-1284. doi: 10.1016/j.imbio.2012.07.001
-
Zhu T, Muthui D, Holte S, 2002: Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy[J]. J Virol, 76, 707-716. doi: 10.1128/JVI.76.2.707-716.2002
-
Ziegler-Heitbrock L, 2007: The CD14+ CD16+ blood monocytes: their role in infection and inflammation[J]. J Leukoc Biol, 81, 584-592. doi: 10.1189/jlb.0806510
-
Ziegler-Heitbrock L, 2015: Blood monocytes and their subsets: established features and open questions[J]. Front Immunol, 6, 423-. doi: 10.3389/fimmu.2015.00423
-
Ziegler-Heitbrock L, Ancuta P, Crowe S, 2010: Nomenclature of monocytes and dendritic cells in blood[J]. Blood, 116, e74-e80. doi: 10.1182/blood-2010-02-258558